Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University clinical trial pipeline

8 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 5 with minor changes only.

1. Notable

   Distribution of the Homologous Recombination-related (HRR)…Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

   Primary and study completion pushed from May 31, 2027 to Dec 31, 2028

   Also in this update: Enrollment closed, study ongoing

   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Not specified· NCT05466786· Registry history of NCT05466786 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

2. Notable

   Camrelizumab Combined With GEMOX for Unresectable GBCs

   Primary completion pushed from Dec 31, 2025 to Dec 31, 2027

   Also in this update: Study completion pushed from Dec 31, 2026 to Dec 31, 2027

   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Phase 2· NCT06423170· Registry history of NCT06423170 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

3. Notable

   Outcomes of Endoscopic-assisted vs Conventional Breast-conserving…Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

   Enrollment reduced: 1380 → 804 participants

   Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University·Not applicable· NCT06716073· Registry history of NCT06716073 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.